These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial. Perrier L, Lefranc A, Pérol D, Quittet P, Schmidt-Tanguy A, Siani C, de Peretti C, Favier B, Biron P, Moreau P, Bay JO, Lissandre S, Jardin F, Espinouse D, Sebban C. Appl Health Econ Health Policy; 2013 Apr; 11(2):129-38. PubMed ID: 23435861 [Abstract] [Full Text] [Related]
11. [Pancytopenia caused by ticlopidine treated with filgrastim. Description of a case]. Tursi A, Modeo ME, Cuccorese G, Cascella AM, Spinazzola AM, Miglietta A. Recenti Prog Med; 2000 Oct; 91(10):511-2. PubMed ID: 11072739 [Abstract] [Full Text] [Related]
12. Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies. Chong Y, Yakushiji H, Ito Y, Kamimura T. Int J Infect Dis; 2010 Sep; 14 Suppl 3():e171-5. PubMed ID: 20471883 [Abstract] [Full Text] [Related]
13. The First Case of Pseudomonas aeruginosa Bacteremic Pneumonia in a Cancer Patient Receiving Pegfilgrastim. Morita F, Hirai Y, Suzuki K, Uehara Y, Mitsuhashi K, Takahashi M, Watanabe S, Naito T. Intern Med; 2017 Sep; 56(15):2039-2042. PubMed ID: 28768977 [Abstract] [Full Text] [Related]